Crowdonomics
WatchlistPortfolio
BioCurity Pharmaceuticals Inc.

Reg CF · Preferred Stock · Jul 2020

ClosedReached targetReg CFPreferred Equity
via StartEngine · last checked Oct 4, 2026View campaign
Raised
$228.5K / $600K max
38% of ceiling · target hit day 3
Investors
198
$1.2K avg
Post-money valuation
$36.6M
pre-money + amount raised

Raised over time

Cumulative raisedInvestors
$238K$119K$0
198990
Jul 30, 2020 · openedMay 1, 2021 · last reading
Target ($10K) hit — Aug 2, 2020, day 3Deadline Apr 30, 2021

Left axis: cumulative dollars raised. Right axis: cumulative investors. Live figures via StartEngine, last checked Oct 4, 2026; investor counts may lag the platform by up to a day.

Financials disclosed in this offering

FY2018–FY2019 · hover for source
$0
−$1.6M
FY2018
$0
−$2.2M
FY2019
RevenueNet income
Metric
FY2018 audited
FY2019
Income statement
Revenue
$0
$0
Cost of goods sold
$0
$0
Net income
-$1,570,893
-$2,191,060
Taxes paid
$0
$0
Balance sheet
Cash
$167,281
$62,215
Accounts receivable
$0
$0
Total assets
$342,484
$222,611
Short-term debt
$780,203
$1,524,330
Long-term debt
$0
$0
Total liabilities
$780,203
$1,524,330
Other
Headcount
1
1

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Amendments to this offering

3 amendments
  1. Feb 24, 2021
    Terms not yet extracted from this filing
    Form C/A on EDGAR ↗
  2. Dec 23, 2020
    Terms not yet extracted from this filing
    Form C/A on EDGAR ↗
  3. Oct 23, 2020
    Terms not yet extracted from this filing
    Form C/A on EDGAR ↗

Each line compares the amendment with the previous filing of this offering. The quoted reason is the issuer’s own statement from the Form C/A.

Deal terms

Pre-money$36.3M
Post-money$36.6M
Price / share$4.25
Shares offered2,352

Offering details

Target$9,996
Max$599,998
Min investment$510
OpenedJul 30, 2020
DeadlineApr 30, 2021
ClosedApr 30, 2021
Days active274

Links & provenance

Campaign pageSEC filingStartEngine listing
Source: Manual
0001665160-20-001007
Last synced Aug 18, 2026

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.